Zobrazeno 1 - 10
of 4 197
pro vyhledávání: ''
Autor:
Liying Zhang, Songcheng Yu, Li Zhang, Lulu Wang, Keliang Fan, Wenqian Huo, Dandan Wei, Pengling Liu, Jian Hou, Tao Jing, Yu Song, Qingqing Xu, Juan Wang, Mian Wang, Xue Liu, Linlin Li, Zhenxing Mao, Xiaotian Liu, Luting Nie, Chongjian Wang
Publikováno v:
Atherosclerosis. 330:14-21
Background and aims We aimed to evaluate the effects of serum testosterone, obesity and their interaction on blood pressure (BP) parameters and hypertension among Chinese rural adults. Methods A total of 6199 adults were recruited from the Henan Rura
Publikováno v:
Atherosclerosis. 328:23-32
Background and aims The thiol transferase glutaredoxin 1 controls redox signaling and cellular functions by regulating the S-glutathionylation status of critical protein thiols. Here we tested the hypothesis that by derepressing the expression of glu
Autor:
M. Wortmann, Andreas S. Peters, Susanne Dihlmann, Dittmar Böckler, Maani Hakimi, Muhammad Arshad
Publikováno v:
Atherosclerosis. 318:8-13
Background and aims Genetic variations between C57Bl/6 mouse substrains are highly relevant to the investigation of cardiovascular disease. We here assessed whether these variations have an impact on the incidence of abdominal aortic aneurysms (AAA)
Autor:
Hemant Giri, Anuradha Sathis, Viswanathan Mohan, Monalisa Dhar, Madhulika Dixit, Ranjani Harish, Akshari Gupta, Shivam Chandel, Jayashree Gopal, Abel Arul Nathan, Sai Kiran Reddy Samawar
Publikováno v:
Atherosclerosis
Background and aims Angiopoietin-2 (ANG-2) mediates endothelial inflammation to initiate atherosclerosis and angiogenesis. Here we determined the serum levels of ANG-2 in hyperinsulinemic subjects and whether insulin increases its expression and rele
Autor:
Lawrence J. Beilin, Jacqueline A. Krysa, Trevor A. Mori, Sally Burrows, Spencer D. Proctor, Donna F. Vine, Rae-Chi Huang
Publikováno v:
Atherosclerosis. 302:20-26
Background and aims Cardiovascular disease (CVD) begins in youth, and is exacerbated by obesity and metabolic syndrome. Apolipoprotein (Apo)B-remnant cholesterol is considered a primary contributor to CVD risk. Fasting plasma apoB48 can be used as a
Autor:
Ding Ding, Chu-wen Ling, Yu-ming Chen, Luo-Shi-Yuan Zuo, Feng Xiong, Yue-Bin Ke, Qing-Wei Zhong
Publikováno v:
Atherosclerosis. 298:7-13
The relationship of polyunsaturated fatty acids (PUFAs) with cardiovascular risk is still controversial. We aimed to determine whether erythrocyte n-3 and n-6 PUFAs are related to the risk of carotid atherosclerosis.From 2008 to 2019, baseline erythr
Autor:
Manal Zabalawi, Russel C. Sequeira, Yan Nie, Xuewei Zhu, Elena Boudyguina, Tiantong Ou, Jennifer H. Madenspacher, Qingxia Zhao, Zhan Wang, Jonathan M. Nelson, Michael B. Fessler
Publikováno v:
Atherosclerosis
Background and aims Dietary long-chain (≥20 carbons) n-3 polyunsaturated fatty acids (PUFAs) reduce atherosclerosis and enhance macrophage autophagy activation. How macrophage autophagy impacts atherosclerotic progression, particularly when compari
Autor:
Julia Dittrich, Christin Helmschrodt, Susen Becker, Holger Staab, Jenny Leopold, Gabriela Aust, Olaf Richter, Uta Ceglarek, Silvio Rohm
Publikováno v:
Atherosclerosis. 295:18-24
Background and aims Circulating sterols result either from cholesterol (CH) synthesis or intestinal uptake. They are mainly esterified and can be oxygenated. Sterols accumulate in atherosclerotic plaques whereby their clinical impact is uncertain. He
Autor:
Kai Kappert, Henryk Dreger, Benjamin Blaschke, Raphaela Fritsche-Guenther, Karl Stangl, Patrizia Brunner, Cornelia Bartsch, Andreas Benn, Yoann Gloaguen, Frederike Kramer, Jennifer A. Kirwan, Eric Witt, Elke Hammer, Angelika Vietzke, Verena Stangl, Petra Knaus, Hoang Giang Nguyen, Mario Lorenz
Publikováno v:
Atherosclerosis. 291:99-106
Background and aims Gonadal hormones are mainly thought to account for sex and gender differences in the incidence, clinical manifestation and therapy of many cardiovascular diseases. However, intrinsic sex differences at the cellular level are mostl
Autor:
Rieko Isoda, Kiminori Hosoda, Mariko Harada-Shiba, Atsushi Takahashi, Yoshihiro Miyamoto, Mika Hori, Masatsune Ogura, Cheol Son, Suguru Yamamoto, Hiroaki Masuda, Naotaka Ohta
Publikováno v:
Atherosclerosis. 289:101-108
Background and aims More than 4970 variants in the low-density lipoprotein receptor (LDLR) gene and 350 variants in the proprotein convertase subtilisin/kexin 9 (PCSK9) gene have been reported in familial hypercholesterolemia (FH) patients. However,